Heterogeneous cell response to topotecan in a CFSE-based proliferation test

Giada Matera, Monica Lupi, Paolo Ubezio

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Background: Carboxyfluorescein diacetate succinimidyl ester (CFSE) is currently used to investigate migration and proliferation of hemopoietic cells. In principle, CFSE is retained by the cells and is shared by the daughter cells at each division, resulting in multimodal flow cytometric CFSE histograms, with each cell generation clustering around half the fluorescence intensity of the previous one. However, intercell variability of CFSE loading results in overlapping peaks, thereby limiting its use with cancer cell lines. Methods: We used IGROV1 ovarian cancer cells loaded with CFSE at the time of seeding; 24 h later cells were treated with an anticancer drug (topotecan). Potential pitfalls of the analysis were examined, and a procedure of evaluation of CFSE efflux was applied to fix the peak positions with good approximation in advance. Histograms were fitted by a series of gaussians, with each representing cells in a given generation. Results: Effects of topotecan on IGROV1 cells were analyzed in terms of the time course of the percentage of cells that remained undivided or entered the second, third, and subsequent division cycles. A simple algorithm, which combined flow cytometric data with the absolute cell number independently measured by Coulter counter, provided an estimate of the 96-h outcome of the starting cell population by quantifying cells that remained undivided, those able to divide at least once, or those that had died. Conclusions: We assessed experimental and data analytic procedures for a CFSE-based measurement of antiproliferative activity of drugs in cancer cell lines. A quantitative level was achievable but required a strict procedure for control of the experimental data, which was not straightforward.

Original languageEnglish
Pages (from-to)118-128
Number of pages11
JournalCytometry Part A
Volume62
Issue number2
DOIs
Publication statusPublished - Dec 2004

Fingerprint

Topotecan
5-(6)-carboxyfluorescein diacetate succinimidyl ester
Cell Line
Pharmaceutical Preparations
Ovarian Neoplasms
Cluster Analysis
Neoplasms
Cell Count
Fluorescence
Cell Proliferation

Keywords

  • Carboxyfluorescein diacetate succinimidyl ester
  • Cell division
  • Cell proliferation
  • Complexity
  • Drug effects
  • Flow cytometry
  • Mathematical models
  • Topotecan

ASJC Scopus subject areas

  • Biophysics
  • Cell Biology
  • Endocrinology
  • Hematology
  • Pathology and Forensic Medicine

Cite this

Heterogeneous cell response to topotecan in a CFSE-based proliferation test. / Matera, Giada; Lupi, Monica; Ubezio, Paolo.

In: Cytometry Part A, Vol. 62, No. 2, 12.2004, p. 118-128.

Research output: Contribution to journalArticle

@article{377e8fe33c3046d39f43987c35a83b4e,
title = "Heterogeneous cell response to topotecan in a CFSE-based proliferation test",
abstract = "Background: Carboxyfluorescein diacetate succinimidyl ester (CFSE) is currently used to investigate migration and proliferation of hemopoietic cells. In principle, CFSE is retained by the cells and is shared by the daughter cells at each division, resulting in multimodal flow cytometric CFSE histograms, with each cell generation clustering around half the fluorescence intensity of the previous one. However, intercell variability of CFSE loading results in overlapping peaks, thereby limiting its use with cancer cell lines. Methods: We used IGROV1 ovarian cancer cells loaded with CFSE at the time of seeding; 24 h later cells were treated with an anticancer drug (topotecan). Potential pitfalls of the analysis were examined, and a procedure of evaluation of CFSE efflux was applied to fix the peak positions with good approximation in advance. Histograms were fitted by a series of gaussians, with each representing cells in a given generation. Results: Effects of topotecan on IGROV1 cells were analyzed in terms of the time course of the percentage of cells that remained undivided or entered the second, third, and subsequent division cycles. A simple algorithm, which combined flow cytometric data with the absolute cell number independently measured by Coulter counter, provided an estimate of the 96-h outcome of the starting cell population by quantifying cells that remained undivided, those able to divide at least once, or those that had died. Conclusions: We assessed experimental and data analytic procedures for a CFSE-based measurement of antiproliferative activity of drugs in cancer cell lines. A quantitative level was achievable but required a strict procedure for control of the experimental data, which was not straightforward.",
keywords = "Carboxyfluorescein diacetate succinimidyl ester, Cell division, Cell proliferation, Complexity, Drug effects, Flow cytometry, Mathematical models, Topotecan",
author = "Giada Matera and Monica Lupi and Paolo Ubezio",
year = "2004",
month = "12",
doi = "10.1002/cyto.a.20097",
language = "English",
volume = "62",
pages = "118--128",
journal = "Cytometry. Part A : the journal of the International Society for Analytical Cytology",
issn = "1552-4922",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Heterogeneous cell response to topotecan in a CFSE-based proliferation test

AU - Matera, Giada

AU - Lupi, Monica

AU - Ubezio, Paolo

PY - 2004/12

Y1 - 2004/12

N2 - Background: Carboxyfluorescein diacetate succinimidyl ester (CFSE) is currently used to investigate migration and proliferation of hemopoietic cells. In principle, CFSE is retained by the cells and is shared by the daughter cells at each division, resulting in multimodal flow cytometric CFSE histograms, with each cell generation clustering around half the fluorescence intensity of the previous one. However, intercell variability of CFSE loading results in overlapping peaks, thereby limiting its use with cancer cell lines. Methods: We used IGROV1 ovarian cancer cells loaded with CFSE at the time of seeding; 24 h later cells were treated with an anticancer drug (topotecan). Potential pitfalls of the analysis were examined, and a procedure of evaluation of CFSE efflux was applied to fix the peak positions with good approximation in advance. Histograms were fitted by a series of gaussians, with each representing cells in a given generation. Results: Effects of topotecan on IGROV1 cells were analyzed in terms of the time course of the percentage of cells that remained undivided or entered the second, third, and subsequent division cycles. A simple algorithm, which combined flow cytometric data with the absolute cell number independently measured by Coulter counter, provided an estimate of the 96-h outcome of the starting cell population by quantifying cells that remained undivided, those able to divide at least once, or those that had died. Conclusions: We assessed experimental and data analytic procedures for a CFSE-based measurement of antiproliferative activity of drugs in cancer cell lines. A quantitative level was achievable but required a strict procedure for control of the experimental data, which was not straightforward.

AB - Background: Carboxyfluorescein diacetate succinimidyl ester (CFSE) is currently used to investigate migration and proliferation of hemopoietic cells. In principle, CFSE is retained by the cells and is shared by the daughter cells at each division, resulting in multimodal flow cytometric CFSE histograms, with each cell generation clustering around half the fluorescence intensity of the previous one. However, intercell variability of CFSE loading results in overlapping peaks, thereby limiting its use with cancer cell lines. Methods: We used IGROV1 ovarian cancer cells loaded with CFSE at the time of seeding; 24 h later cells were treated with an anticancer drug (topotecan). Potential pitfalls of the analysis were examined, and a procedure of evaluation of CFSE efflux was applied to fix the peak positions with good approximation in advance. Histograms were fitted by a series of gaussians, with each representing cells in a given generation. Results: Effects of topotecan on IGROV1 cells were analyzed in terms of the time course of the percentage of cells that remained undivided or entered the second, third, and subsequent division cycles. A simple algorithm, which combined flow cytometric data with the absolute cell number independently measured by Coulter counter, provided an estimate of the 96-h outcome of the starting cell population by quantifying cells that remained undivided, those able to divide at least once, or those that had died. Conclusions: We assessed experimental and data analytic procedures for a CFSE-based measurement of antiproliferative activity of drugs in cancer cell lines. A quantitative level was achievable but required a strict procedure for control of the experimental data, which was not straightforward.

KW - Carboxyfluorescein diacetate succinimidyl ester

KW - Cell division

KW - Cell proliferation

KW - Complexity

KW - Drug effects

KW - Flow cytometry

KW - Mathematical models

KW - Topotecan

UR - http://www.scopus.com/inward/record.url?scp=9644268056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9644268056&partnerID=8YFLogxK

U2 - 10.1002/cyto.a.20097

DO - 10.1002/cyto.a.20097

M3 - Article

C2 - 15536634

AN - SCOPUS:9644268056

VL - 62

SP - 118

EP - 128

JO - Cytometry. Part A : the journal of the International Society for Analytical Cytology

JF - Cytometry. Part A : the journal of the International Society for Analytical Cytology

SN - 1552-4922

IS - 2

ER -